Stevard LLC’s Prothena Corp PRTA Stock Holding History

Stevard LLC’s Portfolio PRTA Stock Details PRTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-10,487	Closed	-$110K	–	173
2020 Q2	$110K	Buy	+10,487	New	+$117K	0.06%	158

Other funds holding PRTA

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Stevard LLC's PRTA Position: Q3 2020 in Review

Stevard LLC sold out of Prothena Corp (PRTA) in Q3 2020, closing a stake of 10,487 shares — an estimated $110K sold.

Stevard LLC first reported a position in PRTA in Q2 2020 and held it in 1 quarter. The position peaked at $110K in Q2 2020. 140 funds tracked by Wall St. Rank hold PRTA as of Q3 2020.

Stevard LLC reported no remaining Prothena Corp position as of Q3 2020 after selling out during the quarter.
Stevard LLC sold 10,487 Prothena Corp shares in Q3 2020, an estimated $110K.
Stevard LLC first reported a position in Prothena Corp in Q2 2020 and held it in 1 quarter.
Stevard LLC's Prothena Corp position peaked at $110K in Q2 2020.
140 funds tracked by Wall St. Rank held Prothena Corp as of Q3 2020.

Based on Stevard LLC's 13F filing for Q3 2020, filed 12 Nov 2020.